NewAmsterdam Pharma

NAMS

Valor de mercado US$ 2,37 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Frazier Life Sciences Management Palo Alto, California	US$ 613 mi	+US$ 37,7 mi	+1.145.128	+7%
2	2 Capital World Investors Los Angeles, California	US$ 414 mi	+US$ 37 mi	+1.121.523	+10%
3	3 Fidelity Investments Boston, Massachusetts	US$ 350 mi	+US$ 51,9 mi	+1.573.852	+18%
4	4 RA Capital Management Boston, Massachusetts	US$ 324 mi	–	–	–
5	5 FCPM III Services Naarden, Netherlands	US$ 288 mi	-US$ 23,3 mi	-708.547	-8%
6	6 Deerfield Management New York	US$ 145 mi	–	–	–
7	7 Viking Global Investors Stamford, Connecticut	US$ 142 mi	–	–	–
8	8 Bain Capital Life Sciences Investors Boston, Massachusetts	US$ 129 mi	-US$ 115 mi	-3.500.000	-48%
9	9 Maverick Capital Dallas, Texas	US$ 111 mi	+US$ 35,6 mi	+1.081.400	+49%
10	DFO 10 Duquesne Family Office New York	US$ 104 mi	–	–	–
11	11 Jupiter Topco New York	US$ 86 mi	+US$ 83,6 mi	+2.535.682	Nova
12	MVM 12 Medicxi Ventures Management St. Helier, Jersey	US$ 74,9 mi	-US$ 15,3 mi	-465.543	-17%
13	13 Jennison Associates New York	US$ 71,2 mi	-US$ 21,4 mi	-648.117	-24%
14	14 Orbis Allan Gray Hamilton, Bermuda	US$ 59,2 mi	+US$ 57,6 mi	+1.747.627	Nova
15	15 Polar Capital Holdings London, United Kingdom	US$ 58,4 mi	-US$ 36,5 mi	-1.107.089	-39%
16	16 Capital International Investors Los Angeles, California	US$ 58,4 mi	+US$ 9,3 mi	+282.364	+20%
17	17 Goldman Sachs New York	US$ 52,4 mi	-US$ 13,2 mi	-401.463	-21%
18	18 Westfield Capital Management Boston, Massachusetts	US$ 52,1 mi	-US$ 22 mi	-666.441	-30%
19	19 Castle Hook Partners New York	US$ 46,5 mi	+US$ 10,8 mi	+328.368	+31%
20	20 Ameriprise Minneapolis, Minnesota	US$ 42,5 mi	+US$ 16,5 mi	+500.495	+66%
21	21 AllianceBernstein Nashville, Tennessee	US$ 40,3 mi	+US$ 2 mi	+60.615	+5%
22	22 T. Rowe Price Associates Baltimore, Maryland	US$ 39,6 mi	+US$ 38,5 mi	+1.167.357	Nova
23	23 JP Morgan Chase New York	US$ 38,4 mi	+US$ 8,2 mi	+248.727	+28%
24	24 Aberdeen Group Edinburgh, United Kingdom	US$ 37,4 mi	+US$ 8,76 mi	+265.780	+32%
25	25 BlackRock New York	US$ 36,1 mi	+US$ 5,84 mi	+177.134	+20%

NewAmsterdam Pharma NAMS Valor de mercado US$ 2,37 bi

NewAmsterdam Pharma

NAMS

Valor de mercado US$ 2,37 bi